14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TRYPF
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Tryp Therapeutics Inc. stock downgraded from Buy Candidate to Hold/Accumulate after Friday trading session.
(Updated on May 03, 2024)

Buy or Hold candidate since Apr 09, 2024 Gain 133.20% PDF

No changes to the price of Tryp Therapeutics Inc. stock on the last trading day (Friday, 3rd May 2024). During the last trading day the stock fluctuated 0% from a day low at $0.0562 to a day high of $0.0562. The price has risen in 5 of the last 10 days and is up by 56.11% over the past 2 weeks.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $0.0566 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 75.44% during the next 3 months and, with a 90% probability hold a price between $0.0401 and $0.0993 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TRYPF Signals & Forecast

The Tryp Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0507 and $0.0299. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 02, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Tuesday, February 27, 2024 with a target of $0.0275. Despite whether the objective of the signal formation has been reached the stock may continue to perform well.

Support, Risk & Stop-loss for Tryp Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0490 and $0.0470. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Tryp Therapeutics Inc. finds support just below today's level at $0.0490. If this is broken, then the next support from accumulated volume will be at $0.0470 and $0.0429.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 23.69%

Our recommended stop-loss: $0.0542 (-3.50%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (TRYPF) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Tryp Therapeutics Inc. to open at $0.0562, and during the day (based on 14 day Average True Range), to move between $0.0509 and $0.0615, which gives a possible trading interval of +/-$0.0053 (+/-9.49%) up or down from last closing price. If Tryp Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 18.99% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $0.0490, some $0.0072 (12.81%) from the current price of $0.0562, our system finds the risk reward attractive.

Is Tryp Therapeutics Inc. stock A Buy?

Tryp Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Tryp Therapeutics Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$0.0562 ( 0%) $0.0562

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TRYPF

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0562 .
R2 0.0562 .
R1 0.0562 .
Current price: 0.0562
Support S1 0.0562 .
S2 0.0562 .
S3 0.0562 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 0.0562
Support S1 0.0490 -12.81%
S2 0.0470 -16.37%
S3 0.0429 -23.67%

FAQ

What is the symbol for Tryp Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Tryp Therapeutics Inc. is TRYPF and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Tryp Therapeutics Inc. Stock?
Tryp Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Tryp Therapeutics Inc. Stock?
Tryp Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Tryp Therapeutics Inc. Stock.

What's the current price of Tryp Therapeutics Inc. Stock?
As of the end of day on the May 03, 2024, the price of an Tryp Therapeutics Inc. (TRYPF) share was $0.0562.

What is the 52-week high and low for Tryp Therapeutics Inc. Stock?
The 52-week high for Tryp Therapeutics Inc. Stock is $0.0919 and the 52-week low is $0.0041.

What is the market capitalization of Tryp Therapeutics Inc. Stock?
As of the May 03, 2024, the market capitalization of Tryp Therapeutics Inc. is 5.419M.
Click to get the best stock tips daily for free!

About Tryp Therapeutics Inc.

Tryp Therapeutics. Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company's lead development program is (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. Its PFN program candidates include TRP-8802 and TRP-8803 for fibromyalgia, phantom limb pain, binge eating disorder, complex regional pain syndro... TRYPF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT